Overview Performance Dividends Fundamentals Peer Group Correlations Pair Trades Institutions Insider Forecasts Options

Performance of OGN Organon & Co | -18.1% in 12m

Compare OGN with Indices, Sectors and Commodities ✔ like Oil, Gas, Gold, Yields and Bonds. Who outperforms?

Compare Organon & Co with its related Sector/Index XLV

Compare Organon & Co with its related Sector/Index XLV

Performance Duell OGN vs XLV

TimeFrame OGN XLV
1 Day 1.89% 0.34%
1 Week 5.00% 0.68%
1 Month 0.53% -4.94%
3 Months 11.8% 0.49%
6 Months 31.8% 14.32%
12 Months -18.1% 6.89%
YTD 30.5% 1.55%
Rel. Perf. 1m 0.58
Rel. Perf. 3m 4.18
Rel. Perf. 6m 1.13
Rel. Perf. 12m -2.63

Is Organon & Co a good stock to buy?

Neither. Based on ValueRay Fundamental Analyses, Organon & Co is currently (April 2024) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of -1.10 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of OGN as of April 2024 is 19.57. This means that OGN is currently overvalued and has a potential downside of 3.54% (Sold with Premium).

Is OGN a buy, sell or hold?

  • Strong Buy: 1
  • Buy: 3
  • Hold: 3
  • Sell: 2
  • Strong Sell: 0
Organon & Co has received a consensus analysts rating of 3.33. Therefor, it is recommend to hold OGN.
Values above 0%: OGN is performing better - Values below 0%: OGN is underperforming

Compare OGN with Broad Market Indices

Symbol 1w 1m 6m 12m
US S&P 500 SPY 2.93% 3.02% 8.15% -42.46%
US NASDAQ 100 QQQ 1.67% 3.07% 7.36% -53.11%
US Dow Jones Industrial 30 DIA 4.63% 3.99% 14.09% -32.77%
German DAX 40 DBXD 3.58% 2.62% 8.89% -31.20%
UK FTSE 100 ISFU 1.65% -1.35% 14.81% -25.39%
Shanghai Shenzhen CSI 300 CSI 300 1.86% -3.04% 29.69% -5.61%
Hongkong Hang Seng HSI -3.34% -3.91% 33.52% 0.73%
Japan Nikkei 225 EXX7 4.69% 8.18% 13.41% -36.34%
India NIFTY 50 INDA 3.77% -1.29% 10.53% -46.04%
Brasil Bovespa EWZ 2.61% 2.60% 20.39% -37.22%

OGN Organon & Co vs. Sectors

Symbol 1w 1m 6m 12m
Communication Services XLC 5.50% 3.57% 8.16% -51.47%
Consumer Discretionary XLY -0.57% 2.65% 12.05% -40.73%
Consumer Staples XLP 4.10% 1.22% 17.94% -18.84%
Energy XLE 4.16% -1.57% 16.22% -35.19%
Financial XLF 5.27% 3.76% 3.32% -43.12%
Health Care XLV 4.32% 5.47% 17.44% -24.94%
Industrial XLI 3.27% 2.50% 4.21% -43.60%
Materials XLB 3.63% 3.35% 11.28% -32.42%
Real Estate XLRE 3.06% 7.26% 16.15% -19.20%
Technology XLK 1.68% 4.17% 8.05% -52.19%
Utilities XLU 3.39% -1.66% 16.38% -18.66%
Aerospace & Defense XAR 1.64% 2.79% 9.91% -38.69%
Biotech XBI 2.89% 10.40% 0.55% -24.70%
Homebuilder XHB 1.48% 6.90% -16.47% -66.60%
Retail XRT 2.58% 7.86% 5.26% -38.93%

OGN Organon & Co vs. Commodities

Symbol 1w 1m 6m 12m
Oil USO 4.09% -0.45% 27.22% -35.83%
Natural Gas UNG 5.86% -1.80% 78.13% 28.78%
Gold GLD 4.72% -4.55% 14.97% -35.03%
Silver SLV 5.40% -8.61% 15.41% -26.01%
Copper CPER 1.51% -15.27% 3.95% -40.02%

Returns of OGN vs. Yields & Bonds

Symbol 1w 1m 6m 12m
iShares 20+ Years Bond TLT 5.02% 6.17% 23.73% -4.72%
iShares High Yield Corp. Bond HYG 4.41% 1.15% 22.28% -26.31%
Does Organon & Co outperform its market, is OGN a Sector Leader?
No, over the last 12 months Organon & Co (OGN) made -18.05%, while its related Sector, the Health Care Sector SPDR Fund (XLV) made 6.89%.
Over the last 3 months OGN made 11.83%, while XLV made 0.49%.
Period OGN XLV S&P 500
1 Month 0.53% -4.94% -2.49%
3 Months 11.83% 0.49% 4.15%
12 Months -18.05% 6.89% 24.41%